AI Strategy

Choose the AI uses that earn their place in your healthcare business

We rank use cases by value, risk and readiness, then name an owner and a success measure for each one before anything is bought.

Short answer

What is AI strategy for healthcare businesses?

AI strategy is the set of decisions about which workflows to apply AI to, in what order, with which data, under whose ownership and against which business result. For a healthcare business it also sets the boundaries: what stays with qualified professionals, what data tools may touch, and what you will not automate at all.

The problem

Problems this service solves

01

Tools bought without a workflow

A scribe in one department, a chatbot in another, a lead-scoring add-on from a conference. Together they create new logins, new data flows and nobody who owns the result.

02

Pilots that never end

A pilot with no success measure agreed in advance cannot succeed or fail, so it simply continues. Leadership cannot decide whether to scale it.

03

No fair way to rank requests

The medical director wants documentation help, the billing manager wants denial support, marketing wants content drafts. Without a scoring method, the loudest request or the most persuasive vendor wins.

04

Time saved that never becomes revenue

The NHS evaluation of ambient tools warns that minutes saved do not automatically turn into extra appointments or cash savings. AI work needs a commercial target, not just an efficiency story.

Context

Why this is harder in healthcare, and where it opens up

What makes it hard

  • Integration is the most-cited barrier to scaling in the McKinsey survey of 150 US healthcare leaders, so a use case that looks simple in a demo can stall on the EHR, phone system or billing platform.
  • Maturity varies by workflow. Clinician-reviewed documentation and bounded back-office tasks have repeatable deployments; agents working claims across systems, or unsupervised clinical triage, do not.
  • Most proofs of concept stall. Bain's adoption index found 24% of pharma AI proofs of concept reached production, against 35% for providers.
  • Frontline staff carry the change. In the AMA survey of 1,692 physicians, 88% expressed at least some concern about skill loss.

Where the opportunity is

  • Pick two or three workflows with a measurable baseline today, such as lead response time, no-show rate or first-pass claim acceptance.
  • Retire or consolidate overlapping tools, which lowers spend and the number of places patient data lives.
  • Give managers one answer when a team asks for a new tool: same scoring, same owner, same measure.
  • Build reusable foundations once, such as a data access pattern and a human review step, so the second use case moves faster than the first.
How it works

The mechanics, in order

  1. 01

    Map goals and the workflows behind them

    We start with what must change this year, such as referral volume, days in accounts receivable or sales cycle length, then walk the workflows that drive it with the people who do the work.

  2. 02

    Score each candidate use case

    Each gets a value score, a risk score (what happens when the tool is wrong, and to whom) and a readiness score covering data, integrations and staff time.

  3. 03

    Decide to build, buy or configure

    We compare configuring something you own, buying a specialist product and building a custom workflow, and assess vendors against your workflow and exit options rather than their demo.

  4. 04

    Set the pilot finish line first

    Each pilot has a named owner, baseline, success measure, stop rule and review date before it starts. A pilot that misses its measure is a useful result.

  5. 05

    Sequence the roadmap and the change

    Early wins build trust and shared foundations, while communication, training and role changes are planned alongside the technology.

Human + AI

What AI does, and what people own

Strategy is a leadership discipline, and AI is an analysis aid inside it. Executives and clinical leads set the boundaries; the tools help us gather and compare evidence faster.

AI handles

  • Summarizes interview notes, process documents and vendor materials.
  • Clusters workflow pain points from staff feedback and ticket histories.
  • Drafts scoring tables, comparison matrices and pilot plans for review.
  • Flags mismatches between a vendor's claims, its contract and your requirements.

People decide and review

  • The CEO or managing partner decides which commercial objectives AI serves and how much risk to accept.
  • The medical director sets the boundary for anything touching clinical judgment.
  • The compliance officer reviews data flows, vendor terms and patient-facing disclosure.
  • Department heads own each use case and the decision to scale, change or stop.
What we build

What is included

01

Use-case inventory and scoring

One list of every AI idea and tool already in use, scored on value, risk and readiness with criteria leadership agrees.

02

Build, buy or configure analysis

A side-by-side view of the three paths, including effort, data needs, ownership and the cost of leaving.

03

Vendor and tool assessment

A checklist for workflow fit, data handling and support. Where a product must talk to your systems, we scope the data and integrations work up front.

04

Pilot design and measurement

Baselines, success measures and stop rules written before launch, using numbers you already track.

05

Roadmap and sequencing

A phased plan ordered by dependency and trust, with named owners and a review rhythm leaders can keep.

06

Ownership and change plan

Who owns each use case, who is trained, which roles change and how staff concerns are heard.

Use cases

Examples from healthcare operations

Illustrations of how this work looks in practice. They describe workflows, not client results.

Ranking a backlog for a multi-site group

A group receiving separate AI requests from every site scores them together, picks those that share infrastructure and defers the rest with a written reason.

MSOs & Groups

Vendor selection for a billing company

A billing company tests coding support tools against its own sample of denied claims and decides which part to buy and which to configure.

Medical Billing & RCM

Choosing a first pilot for a service line

A service line leader picks one patient access workflow that sits next to the EHR vendor's tools, and writes the measure before the pilot starts.

Hospitals & Systems

Bringing hidden AI use into the open

A practice manager learns staff paste referral details into a public tool. The strategy sets approved tools, a rule on protected health information and a route for requesting new ones.

Medical Clinics
Growth link

A roadmap that points at revenue, not novelty

AI work matters commercially only if it changes a number the business already tracks. We tie each use case to attract, convert, retain or grow, and connect the roadmap to your go-to-market plan so the same priorities drive both.

  • Attract: faster lead response and referral intake for the segments you want to win.
  • Convert: workflows that move an inquiry to a booked consult or demo, with a person at the decision point.
  • Retain: recall, rebooking and onboarding steps where a missed follow-up costs revenue.
  • Protect: a written risk position that answers a hospital procurement team or payer security questionnaire without scrambling.
Our approach

How an engagement runs

Phase 1

Listen and baseline

Interviews with leaders and frontline staff, a review of current tools and spend, and a baseline for the numbers you want to move.

Phase 2

Score and shortlist

A scored inventory, a build, buy or configure view for each item, and a shortlist leaders can approve in one meeting.

Phase 3

Pilot with discipline

We support the first pilots with whichever path scored best, whether a configured tool, AI agents for patient access or a workflow automation.

Phase 4

Decide, sequence and hand over

Read results against the measures, scale, change or stop each pilot, and leave your team the scoring method and review rhythm.

Outcomes

What usually improves

01

A shorter, ranked list

The aim is a shorter list of active initiatives, each with an owner and a measure.

02

Fewer overlapping tools

Duplicate subscriptions and tools nobody owns are flagged for retirement or consolidation.

03

Calmer vendor conversations

Procurement runs against a written checklist and your own workflow.

04

Clearer pilot decisions

Leaders can say scale, change or stop, and point to the baseline and result behind it.

What this depends on

What improves depends on your starting point, data quality, how well your systems connect and whether people adopt the change. A strategy cannot create capacity your workflows do not release, and we do not promise a particular return. Survey figures are not a forecast for your business, so each pilot is judged against your own baseline.

Limits

What to watch out for

  • A strategy is not a compliance determination. HIPAA obligations apply now to protected health information in any AI use, and the January 2025 Security Rule proposal is still not final as of October 2026. Check with qualified counsel before relying on a specific legal reading.
  • The NIST AI Risk Management Framework is voluntary. We use it, and its generative AI profile of 26 July 2024, to structure inventory, ownership and monitoring, but no framework certifies that an output is safe.
  • Saved time is not saved money. The Nuffield Trust review of ambient voice technology notes that downstream safety, capacity and cash-releasing savings are not yet proven, so we measure them directly.
  • Software that moves from administrative support into diagnosis, treatment or automated clinical action raises device regulation questions in the US and UK. We flag that boundary early; regulatory specialists decide it.
Questions

Frequently asked questions

How is an AI strategy different from buying an AI tool?

A tool answers one task. A strategy decides which tasks matter, in what order and who owns the result. Without one, each department buys its own product and the business inherits overlapping logins and nobody accountable.

We already use a scribe or a chatbot. Do we still need a strategy?

Yes, and it is often more useful then. An existing tool shows what adoption really looks like in your team. We decide whether to keep, consolidate or replace it, and connect it to AI governance so it has a policy and an owner.

How do you decide between building, buying and configuring?

We score each path on workflow fit, data access, security terms, effort and the cost of leaving. Configuring something you own is often the lowest-risk start. Buying suits mature, bounded tasks, and a custom build is reserved for workflows specific to your business.

Can you tell us how many similar businesses run AI in production?

Only as far as the research allows. A McKinsey survey of 150 US healthcare leaders reported 50% implementing gen-AI and 19% implementing agentic AI, with 51% pursuing agentic proofs of concept. That is a small sample from late 2025, so we judge your options against your own workflows.

Will you recommend specific vendors?

We recommend criteria and a shortlist for your situation. We do not sell AI tools, so the assessment is about fit rather than quota. If configuring what you already own is enough, we will say so.

What if our data is not ready?

Then the roadmap says so plainly. Data quality, patient matching and system access are scored as readiness, and use cases that depend on missing data move later or begin with the data and integrations work they depend on. Staff time for training is scored the same way.

Start with a ranked list, not another subscription

Book a discovery call and bring your current tools, your biggest operational frustrations and the numbers you want to move. We will tell you what is worth doing first and what is not.

Book a discovery call
error: Content is protected !!